Loading…
Core Laboratories Inc. is projected to rise to $11.39 by 2027, a +7% move from its current price of $10.64. CLB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $10.33 | $10.63 | $10.95 | -0.06% |
| Aug 4 | $10.20 | $10.63 | $11.07 | -0.11% |
| Aug 5 | $10.10 | $10.62 | $11.17 | -0.17% |
| Aug 6 | $10.02 | $10.62 | $11.25 | -0.22% |
| Aug 7 | $9.94 | $10.61 | $11.32 | -0.28% |
| Aug 8 | $9.88 | $10.60 | $11.39 | -0.33% |
| Aug 9 | $9.82 | $10.60 | $11.44 | -0.39% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.82 | $10.60 | $11.44 | -0.39% |
| Week 2 | $9.47 | $10.56 | $11.77 | -0.77% |
| Week 3 | $9.21 | $10.52 | $12.01 | -1.16% |
| Week 4 | $8.98 | $10.48 | $12.21 | -1.54% |
| Week 5 | $8.79 | $10.44 | $12.39 | -1.92% |
| Week 6 | $8.61 | $10.39 | $12.55 | -2.31% |
| Week 7 | $8.45 | $10.35 | $12.69 | -2.68% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments.
The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities.
The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors.
Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Core Laboratories Inc. (CLB) is an energy sector stock with a current price of $10.64.
Its market capitalization is $488.21M and its market rank is 2924.
The year-by-year forecast shows a path from the current price to higher levels over time. In 2026, the average price is $10.64 with neutral sentiment and a 0% ROI. In 2027, the average is $11.39 with neutral sentiment and a 7% ROI.
The forecast envisions a bullish trajectory with 2028 average $14.02 (ROI 31.7%), 2029 $13.98 (ROI 31.4%), 2030 $14.76 (ROI 38.7%), 2040 $24.00 (ROI 125.6%), and 2050 $42.22 (ROI 296.8%).
A major floor 17.9% below — a decisive break under it would weaken the trend.
The nearest floor, 7.2% below — buyers have tended to step in here.
The nearest ceiling, 12.4% above — a clean break opens room to run.
A major ceiling 65.5% above — clearing it would confirm fresh momentum.
Key CLB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $10.56 | Buy | $10.64 | Buy |
| MA 10 | $11.08 | Sell | $10.89 | Sell |
| MA 20 | $11.16 | Sell | $11.17 | Sell |
| MA 50 | $12.11 | Sell | $12.10 | Sell |
| MA 100 | $13.92 | Sell | $13.33 | Sell |
| MA 200 | $15.35 | Sell | $14.23 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 41.43 | Neutral |
| Stoch RSI (14) | 48.92 | Neutral |
| CCI (20) | -94.41 | Neutral |
| Williams %R (14) | -63.16 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -6.34 | Sell |
| Bollinger %B (20,2) | 0.23 | Neutral |
| Stochastic %K (14) | 36.84 | Neutral |
| TRIX (15) | -0.39 | Sell |
| Awesome (5,34) | -0.80 | Sell |
| Ultimate (7,14,28) | 33.17 | Neutral |
| Momentum (10) | -0.70 | Sell |
| Aroon Osc (25) | -20.00 | Sell |
| Hull MA (9) | 9.97 | Buy |
| ADX (14) | 19.67 | Neutral |
| ATR (14) | 0.33 | Info |
The 30-day technical picture shows a BEARISH sentiment.
RSI(14) is 40, with the price trading below key moving averages. The SMA50 is $12.11, and the SMA200 is $15.35, indicating near-term weakness relative to longer-term trend lines.
Support is at $9.87 and resistance at $11.96. The 30-day price range spans from $8.79 to $12.88, and the annualized volatility is 60.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.87 | $10.64 | $12.36 | 0% | Neutral | |
| $9.03 | $11.39 | $15.21 | +7% | Neutral | |
| $10.78 | $14.02 | $19.48 | +32% | Bullish | |
| $10.49 | $13.98 | $20.04 | +31% | Bullish | |
| $10.83 | $14.76 | $21.70 | +39% | Bullish | |
| $10.75 | $14.94 | $22.48 | +40% | Bullish | |
| $10.27 | $14.55 | $22.33 | +37% | Bullish | |
| $10.84 | $15.62 | $24.41 | +47% | Bullish | |
| $11.81 | $17.31 | $27.50 | +63% | Bullish | |
| $13.53 | $20.14 | $32.51 | +89% | Bullish | |
| $14.99 | $24.00 | $41.32 | +126% | Bullish | |
| $23.23 | $42.22 | $79.82 | +297% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $9.87 | $10.64 | $12.42 | +0.00% |
| September 2026 | $8.41 | $9.97 | $12.16 | -6.33% |
| October 2026 | $8.47 | $10.11 | $12.48 | +1.49% |
| November 2026 | $8.45 | $10.15 | $12.64 | +0.35% |
| December 2026 | $8.15 | $9.84 | $12.36 | -3.01% |
Click any year to see its month-by-month CLB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CLB price prediction for 2026 points to an average of $10.64 (low $9.87, high $12.36) — a potential gain of 0% on today's $10.64. Price action looks broadly range-bound.
In 2027, CLB is projected to trade between $9.03 and $15.21, averaging $11.39 — a potential gain of +7% from today's $10.64. That is up +7% on the projected 2026 average. A consolidation phase looks the most probable path here.
Core Laboratories Inc.'s 2028 outlook centres on $14.02, within a $10.78 to $19.48 range. That is up +23% on the projected 2027 average. That marks a +32% change versus current levels. Momentum favours further upside here.
By 2029, CLB could reach as high as $20.04, with a base case around $13.98 and support toward $10.49 — roughly +31% from $10.64. Buyers look set to stay in control over this stretch.
Expect CLB to range from $10.83 to $21.70 through 2030. The $14.76 average target implies a +39% move from current prices. That is up +6% on the projected 2029 average. Momentum favours further upside here.
The CLB price prediction for 2031 points to an average of $14.94 (low $10.75, high $22.48) — a potential gain of +40% on today's $10.64. Buyers look set to stay in control over this stretch.
In 2032, CLB is projected to trade between $10.27 and $22.33, averaging $14.55 — a potential gain of +37% from today's $10.64. That is -3% versus the projected 2031 average. Momentum favours further upside here.
Core Laboratories Inc.'s 2033 outlook centres on $15.62, within a $10.84 to $24.41 range. That is up +7% on the projected 2032 average. That marks a +47% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, CLB could reach as high as $27.50, with a base case around $17.31 and support toward $11.81 — roughly +63% from $10.64. Momentum favours further upside here.
Expect CLB to range from $13.53 to $32.51 through 2035. The $20.14 average target implies a +89% move from current prices. That is up +16% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The CLB price prediction for 2040 points to an average of $24.00 (low $14.99, high $41.32) — a potential gain of +126% on today's $10.64. Momentum favours further upside here.
In 2050, CLB is projected to trade between $23.23 and $79.82, averaging $42.22 — a potential gain of +297% from today's $10.64. That is up +76% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in CLB today (≈ 93.984962 CLB) could be worth
$3,967.78
+$2,967.78 (+297%) by 2050 · US Dollar
Based on the average projected CLB price of $42.22 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLBwould be worth at today's price.
$1,000 invested in CLB on Jul 31, 2025 (≈ 91.407682 CLB) would be worth
$972.58
-$27.42 (-2.7%) today · 0.97× · US Dollar
Based on a CLB entry price of $10.94 vs. today's $10.64.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.67 | $911.74 | -8.8% |
| 1 month ago | $11.57 | $919.62 | -8.0% |
| 3 months ago | $14.07 | $756.22 | -24.4% |
| 6 months ago | $19.59 | $543.13 | -45.7% |
| 1 year ago | $10.94 | $972.58 | -2.7% |
| All time (5.0y) ago | $32.96 | $322.82 | -67.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLB forecast.
Our base-case forecast reaches $21.00 around 2040.
Implied market cap at $21.00: $963.58M
The multi-year forecast points to a neutral stance in 2026 and 2027, followed by stronger upside into later years. The 2028 average is $14.02 with a bullish sentiment and a 31.7% ROI, and the 2029 average is $13.98 with a 31.4% ROI.
Looking ahead to 2030, the average price is projected at $14.76 with an 38.7% ROI, and 2031 at $14.94 with a 40.5% ROI. The 2032 forecast is $14.55 (36.7% ROI), 2033 $15.62 (46.8% ROI), 2034 $17.31 (62.7% ROI), and 2035 $20.14 (89.3% ROI).
Into 2040, the average rises to $24.00 with a 125.6% ROI, and by 2050 the average is $42.22 with a 296.8% ROI, indicating a bullish long-term trajectory.
Tap a question to reveal the answer.
2030 avg $14.76; min $10.83; max $21.70; ROI 38.7%; sentiment bullish.
Near term (2026) shows an average price of $10.64 with neutral sentiment and 0% ROI; 2027 avg $11.39 with neutral sentiment and 7% ROI. From 2028 onward, forecasts are bullish with 2030 avg $14.76 (ROI 38.7%), 2040 avg $24.00 (ROI 125.6%), and 2050 avg $42.22 (ROI 296.8%). These are estimates, not guarantees.
The forecast maximum for 2050 is $79.82, which is just under $80.
$8.79 to $12.88.
Current price is $10.64 and market capitalization is $488.21M.
Core Laboratories Inc. Community Discussion
0Share your Core Laboratories Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.